These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 699858)

  • 1. Oral disopyramide in the prevention of ventricular arrhythmias following myocardial infarction in patients managed on the coronary care unit and open ward.
    Kidner PH; Carmichael DJ
    East Afr Med J; 1978 Aug; 55(8):403-6. PubMed ID: 699858
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of oral disopyramide on mortality and extension of infarction in cases of acute myocardial infarction admitted to open wards.
    Sharma BD; Chug S; Mathur KP
    J Assoc Physicians India; 1983 Mar; 31(3):149-51. PubMed ID: 6352667
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.
    Zainal N; Carmichael DJ; Griffiths JW; Besterman EM; Kidner PH; Gillham AD; Summers GD
    Lancet; 1977 Oct; 2(8044):887-9. PubMed ID: 72237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction.
    Jennings G; Jones MS; Besterman EM; Model DG; Turner PP; Kidner PH
    Lancet; 1976 Jan; 1(7950):51-4. PubMed ID: 54578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous and oral disopyramide after myocardial infarction.
    Nicholls DP; Haybyrne T; Barnes PC
    Lancet; 1980 Nov; 2(8201):936-8. PubMed ID: 6107587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction.
    Pouleur H; Chaudron JM; Reyns P
    Eur J Cardiol; 1977 Jul; 5(5):397-404. PubMed ID: 330168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprophylaxis of arrhythmias with oral disopyramide in acute myocardial infarction.
    Nigam P; Khan S; Singh R; Kapoor KK; Kumar A; Gupta AK
    J Assoc Physicians India; 1983 Dec; 31(12):759-62. PubMed ID: 6370949
    [No Abstract]   [Full Text] [Related]  

  • 8. Arrhythmia prevention in early myocardial infarction.
    Ward JW
    Lancet; 1977 May; 1(8019):1006. PubMed ID: 67440
    [No Abstract]   [Full Text] [Related]  

  • 9. Disopyramide in the treatment and prevention of arrhythmias following myocardial infarction.
    Zainal N; Jennings G; Jones B; Model D; Turner P; Besterman EM; Kidner PH
    J Int Med Res; 1976; 4(1 Suppl):71-3. PubMed ID: 799982
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimens.
    Ward JW; Kinghorn GR
    J Int Med Res; 1976; 4(1 Suppl):49-53. PubMed ID: 1026529
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical observations on effects of disopyramide on arrhythmias].
    Hu BL; Tao SQ; Liu LS; Chen ZJ; Lu ZL; Wang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Jun; 3 Suppl 1():60-2. PubMed ID: 6459881
    [No Abstract]   [Full Text] [Related]  

  • 12. [Complications of acute myocardial infarct (AMI) and their prevention. Experience at a small intensive coronary care unit (ICU)].
    Mascaretti L; Maestri G; Taormina G; Ventura V
    G Clin Med; 1975; 56(9-10):363-76. PubMed ID: 1228052
    [No Abstract]   [Full Text] [Related]  

  • 13. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic effects of oral disopyramide in patients with acute myocardial infarction].
    Bassan R; Miqueloti P; de Souza MA; Luz FS
    Arq Bras Cardiol; 1982 Nov; 39(5):355-7. PubMed ID: 7186390
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial.
    Sbarbaro JA; Rawling DA; Fozzard HA
    Am J Cardiol; 1979 Sep; 44(3):513-20. PubMed ID: 474432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiarrhythmic effect of intravenous disopyramide in an open study.
    Tonkin AM; Heddle WF; Bett JH; Kemp RJ; Donnelly GL; Nelson GI; Manolas E; Sloman JG
    Aust N Z J Med; 1982 Aug; 12(4):271-5. PubMed ID: 6958238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congestive heart failure caused by oral disopyramide.
    Podrid PJ; Schoeneberger A; Lown B
    N Engl J Med; 1980 Mar; 302(11):614-7. PubMed ID: 7351909
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of bretylium tosylate on ventricular arrhythmias in patients with acute myocardial infarction].
    Kochmański M; Rdzanek H; Zochowski RJ
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):901-4. PubMed ID: 1341893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.